BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31535668)

  • 61. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
    Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
    Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.
    Ke Z; Liu Y; Zhang Y; Li J; Kuang M; Peng S; Liang J; Yu S; Su L; Chen L; Sun C; Li B; Cao J; Lv W; Xiao H
    Oncol Rep; 2018 Aug; 40(2):659-668. PubMed ID: 29901149
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules.
    Wu JX; Young S; Hung ML; Li N; Yang SE; Cheung DS; Yeh MW; Livhits MJ
    Thyroid; 2016 Jul; 26(7):916-22. PubMed ID: 27161519
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance.
    Yoo WS; Choi HS; Cho SW; Moon JH; Kim KW; Park HJ; Park SY; Choi SI; Choi SH; Lim S; Yi KH; Park DJ; Jang HC; Park YJ
    Clin Endocrinol (Oxf); 2014 May; 80(5):735-42. PubMed ID: 24117478
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thyroid ultrasonographic charasteristics and Bethesda results after FNAB.
    Triantafillou E; Papadakis G; Kanouta F; Kalaitzidou S; Drosou A; Sapera A; Tampouratzi D; Kotis M; Kyrimis T; Dracopoulou A; Veniou E; Karavasili C; Kaltzidou V; Plyta S; Tertipi A
    J BUON; 2018 Dec; 23(7):139-143. PubMed ID: 30722123
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
    Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
    Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
    Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
    Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
    Jug RC; Datto MB; Jiang XS
    Cancer Cytopathol; 2018 Jul; 126(7):471-480. PubMed ID: 29637728
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Hang JF; Westra WH; Cooper DS; Ali SZ
    Cancer Cytopathol; 2017 Sep; 125(9):683-691. PubMed ID: 28544601
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
    Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
    Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
    Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
    Buryk MA; Simons JP; Picarsic J; Monaco SE; Ozolek JA; Joyce J; Gurtunca N; Nikiforov YE; Feldman Witchel S
    Thyroid; 2015 Apr; 25(4):392-400. PubMed ID: 25627462
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
    Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
    Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutation profiles of follicular thyroid tumors by targeted sequencing.
    Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
    Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.